CAPITAL RIESGO: FINAVES
Descripción de la empresa: Gerium Medical’s mission is to develop state-of-the-art medical devices in the field of medical optics. Currently under development, Gerium Medical’s newest product, BiliCare, measures transcutaneous bilirubin in newborns using a non-invasive method. Future products will measure other substances from other parts of the human body.
ENCUESTA REALIZADA A EMPRESAS CAPITAL RIESGO Y BUSINESS ANGEL EN ESPAÑA APORTADA POR: Adelaide Cracco
Porque la hemos seleccionado: Primera empresa que crea un dispositivo para el control de la bilirrubina.
Gerium Medical developed a non-invasive bilirubin meter for newborns called BiliCare™. The technology of the device is based on a field in physics called spectroscopy—measuring substances using light at varying wave lengths (visible or non-visible light). Gerium Medical’s BiliCare measures the level of transcutaneous bilirubin in the newborn by transmitting light at different wave lengths through the newborn’s ear and measures the intensity of those wave lengths when they come out of the ear. The amount of light absorbed by the bilirubin is calculated by comparing the intensity of the light before it enters the tissue with its intensity after it leaves. Then the transcutaneous bilirubin of the newborn is calculated according to a customized algorithm.